Biomedical Research Foundation Report issue

Foundation Phase 3

Organization Overview

First Clinical Trial
2012
NCT01726088
First Marketed Drug
2015
sodium fluoride-18f
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

BIOMEDCL RES FDN